| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.029 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.9 |